{
    "2021-05-10": [
        [
            {
                "time": "2021-Q1",
                "original_text": "华兰生物(002007)2021年一季报点评：预计新冠疫情影响之后基本消除 全年血制品有望恢复稳定增长",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "新冠疫情影响",
                        "血制品",
                        "稳定增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-14",
                "original_text": "华兰生物(002007.SZ)：19.5万股限制性股票于5月14日上市流通",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "限制性股票",
                        "上市流通"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-Annual/2021-Q1",
                "original_text": "平安证券--生物医药行业2020年报及2021一季度综述：医药行业业绩增速逐季上行，子行业持续分化【行业研究】",
                "features": {
                    "keywords": [
                        "平安证券",
                        "生物医药行业",
                        "业绩增速",
                        "子行业分化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "近期",
                "original_text": "机构调研密集出击 医药行业门庭若市",
                "features": {
                    "keywords": [
                        "机构调研",
                        "医药行业",
                        "密集出击"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}